{"id":6194,"date":"2020-03-13T09:33:31","date_gmt":"2020-03-13T13:33:31","guid":{"rendered":"https:\/\/perspectives.agf.com\/?p=6194"},"modified":"2020-05-01T13:37:55","modified_gmt":"2020-05-01T17:37:55","slug":"biotech-and-the-race-for-a-vaccine","status":"publish","type":"post","link":"https:\/\/perspectives.agf.com\/biotech-and-the-race-for-a-vaccine\/","title":{"rendered":"Biotech and the Race for a Vaccine"},"content":{"rendered":"\n<p>Carmen Tang, AGF equity analyst, discusses the efforts now ongoing across the biotechnology sector to help combat the COVID-19 virus.<\/p>\n\n\n\n<figure class=\"wp-block-embed-youtube wp-block-embed is-type-video is-provider-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\"  id=\"_ytid_88884\"  width=\"640\" height=\"360\"  data-origwidth=\"640\" data-origheight=\"360\" src=\"https:\/\/www.youtube-nocookie.com\/embed\/cR832pZPYIs?enablejsapi=1&#038;origin=https:\/\/perspectives.agf.com&#038;autoplay=0&#038;cc_load_policy=1&#038;cc_lang_pref=&#038;iv_load_policy=1&#038;loop=0&#038;modestbranding=1&#038;rel=0&#038;fs=1&#038;playsinline=0&#038;autohide=2&#038;theme=dark&#038;color=red&#038;controls=1&#038;\" class=\"__youtube_prefs__  epyt-is-override  no-lazyload\" title=\"Biotech and the Race for a Vaccine\"  allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture\" allowfullscreen data-no-lazy=\"1\" data-skipgform_ajax_framebjll=\"\"><\/iframe>\n<\/div><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Carmen Tang, AGF equity analyst, discusses the efforts now ongoing across the biotechnology sector to help combat the COVID-19 virus.<\/p>\n","protected":false},"author":65,"featured_media":6196,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[4],"tags":[1007,767,632,371],"acf":[],"lang":"en","translations":{"fr":6202,"en":6194},"pll_sync_post":[],"_links":{"self":[{"href":"https:\/\/perspectives.agf.com\/wp-json\/wp\/v2\/posts\/6194"}],"collection":[{"href":"https:\/\/perspectives.agf.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/perspectives.agf.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/perspectives.agf.com\/wp-json\/wp\/v2\/users\/65"}],"replies":[{"embeddable":true,"href":"https:\/\/perspectives.agf.com\/wp-json\/wp\/v2\/comments?post=6194"}],"version-history":[{"count":0,"href":"https:\/\/perspectives.agf.com\/wp-json\/wp\/v2\/posts\/6194\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/perspectives.agf.com\/wp-json\/wp\/v2\/media\/6196"}],"wp:attachment":[{"href":"https:\/\/perspectives.agf.com\/wp-json\/wp\/v2\/media?parent=6194"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/perspectives.agf.com\/wp-json\/wp\/v2\/categories?post=6194"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/perspectives.agf.com\/wp-json\/wp\/v2\/tags?post=6194"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}